PlainPill

ALCAR

Also known as Acetyl-L-Carnitine

The short answer. More people than not who report on ALCAR say it helped (64% of 428). It is most often used for energy: 95% of 234 reports say that improved. It is well studied — 46 meta-analyses on PubMed. The most common complaint is anxiety.

What users report
64%helped428 reports · high confidence
274 helped83 mixed71 didn't help

From 1,190 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
46
meta-analyses
86
RCTs
1,179
papers

What ALCAR does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 46 meta-analyses on PubMed ↗ · 86 randomized trials ↗

Cochrane Database Syst Rev · 2003 · Meta-analysis / systematic review
Acetyl-L-carnitine for dementia

Conclusion: There is evidence for benefit of ALC on clinical global impression, but there was no evidence using objective assessments in any other area of outcome. Given the large number of comparisons made, the statistically significant result may be due to chance. At present there is no evidence to recommend its routine use in clinical practice. Although the intention of the review was to access ALC for the treatment of all dementias, the included trials had confined themselves to participants with Alzheimer's disease. Individual patient data may add to the findings, as would trials including other type

PubMed 12804452 ↗
Nutrients · 2020 · Meta-analysis / systematic review
Dietary Interventions in the Management of Fibromyalgia: A Systematic Review and Best-Evidence Synthesis

Conclusion: Interpretation of these studies was limited due to the frequent poor quality of the study design, the wide heterogeneity between studies, the small sample size and a high degree of bias. Therefore, there is insufficient evidence to recommend any one particular nutritional intervention for the management of fibromyalgia and further research is needed.

PubMed 32878326 ↗
World J Biol Psychiatry · 2022 · Meta-analysis / systematic review
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce

Conclusion: Based on the current data and clinician input, a range of nutraceuticals and phytoceuticals were given either a supportive recommendation or a provisional recommendation across a range of various psychiatric disorders. However several had only a weak endorsement for potential use; for a few it was not possible to reach a clear recommendation direction, largely due to mixed study findings; while some other agents showed no obvious therapeutic benefit and were clearly not recommended for use. It is the intention of these guidelines to inform psychiatric/medical, and health professional practice

PubMed 35311615 ↗
Registered clinical trials

67 human trials on ClinicalTrials.gov test ALCAR — 45 completed, 1 recruiting now. See all on ClinicalTrials.gov ↗

Reports to the FDA

Adverse-event reports about supplements containing it, submitted to the US FDA by consumers and doctors.

37 reports name a product containing ALCAR (2009–2024); 18 involved hospitalization or worse. Most often reported:

  • Fatigue · 4
  • Headache · 4
  • Dyspnoea · 4
  • Diarrhoea · 4
  • Nausea · 4
  • Gastrointestinal disorder · 3

A report doesn't prove the supplement caused the problem — many products contain several ingredients, and these counts can't tell you how often it happens. Source: FDA CAERS ↗ · raw reports (openFDA) ↗.

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

US government research funding (NIH)

NIH has funded 6 research projects with ALCAR in the title, $1,226,811 in total (1996–2022). NIH RePORTER ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

1000 mgas reported
500 mg - 1 gdaily
250 mgmorning and evening
500 mgdaily
500-1000 mgin the morning
500mgas reported

Reported side effects

How often each side effect came up across all reports.

anxiety ×25insomnia ×16irritability ×12stomach issues ×6jitteriness ×4anger ×2drowsiness ×2tingling ×1

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“ALCAR is great. Great energy burst. I find it takes a few hours to kick in though.”
HelpedRead the discussion ↗
“I took Acetyl L-Carnatine twice a day for a couple of weeks. It made me fell depressed and sad. First day I stopped the L-Canatine the blues evaporated.”
Didn't helpRead the discussion ↗
“I started taking mitochondrial supplements like pqq and alcar, and they helped me immensely at first but for the past few months, anything I take makes me feel worse.”
MixedRead the discussion ↗
“ALCAR , magnesium bisglycinate and zinc bisglycinate and non-iodized sea salt have completely changed my life.”
HelpedRead the discussion ↗
Read more ALCAR reviews →
Top discussions (5)

ALCAR compared

Other options for energy

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate